These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3884114)

  • 1. A double-blind controlled pilot study of plasma exchange versus sham apheresis in chronic progressive multiple sclerosis.
    Gordon PA; Carroll DJ; Etches WS; Jeffrey V; Marsh L; Morrice BL; Olmstead D; Warren KG
    Can J Neurol Sci; 1985 Feb; 12(1):39-44. PubMed ID: 3884114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Canadian cooperative trial of cyclophosphamide and plasma exchange in progressive multiple sclerosis. The Canadian Cooperative Multiple Sclerosis Study Group.
    Lancet; 1991 Feb; 337(8739):441-6. PubMed ID: 1671468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind study of true vs. sham plasma exchange in patients treated with immunosuppression for acute attacks of multiple sclerosis.
    Weiner HL; Dau PC; Khatri BO; Petajan JH; Birnbaum G; McQuillen MP; Fosburg MT; Feldstein M; Orav EJ
    Neurology; 1989 Sep; 39(9):1143-9. PubMed ID: 2549450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of blinding on the results of a randomized, placebo-controlled multiple sclerosis clinical trial.
    Noseworthy JH; Ebers GC; Vandervoort MK; Farquhar RE; Yetisir E; Roberts R
    Neurology; 1994 Jan; 44(1):16-20. PubMed ID: 8290055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH.
    Hauser SL; Dawson DM; Lehrich JR; Beal MF; Kevy SV; Propper RD; Mills JA; Weiner HL
    N Engl J Med; 1983 Jan; 308(4):173-80. PubMed ID: 6294517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma exchange in multiple sclerosis.
    Guarnieri BM; Capparelli R; Fratiglioni L; Inzitari D; Sità D; Amaducci L; Avanzi G; Biani D; Franco C; Lombardo R
    Int J Artif Organs; 1985 Jul; 8(4):215-20. PubMed ID: 3902665
    [No Abstract]   [Full Text] [Related]  

  • 7. Azathioprine in multiple sclerosis: the cons.
    Silberberg DH
    Neurology; 1988 Jul; 38(7 Suppl 2):24-7. PubMed ID: 3290710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmapheresis in multiple sclerosis: prospective trial of pheresis and immunosuppression versus immunosuppression alone.
    Tindall RS; Walker JE; Ehle AL; Near L; Rollins J; Becker D
    Neurology; 1982 Jul; 32(7):739-43. PubMed ID: 7201110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-masked trial of azathioprine in multiple sclerosis. British and Dutch Multiple Sclerosis Azathioprine Trial Group.
    Lancet; 1988 Jul; 2(8604):179-83. PubMed ID: 2899660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blind, randomized controlled trial of therapeutic plasma exchanges vs sham exchanges in moderate-to-severe relapses of multiple sclerosis.
    Brochet B; Deloire M; Germain C; Ouallet JC; Wittkop L; Dulau C; Perez P; Thevenot F; De Sèze J; Zéphir H; Vermersch P; Pittion S; Debouverie M; Laplaud DA; Clavelou P; Ruet A
    J Clin Apher; 2020 Aug; 35(4):281-289. PubMed ID: 32369661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modified total lymphoid irradiation and low dose corticosteroids in progressive multiple sclerosis.
    Cook SD; Devereux C; Troiano R; Wolansky L; Guarnaccia J; Haffty B; Bansil S; Goldstein J; Sheffet A; Zito G; Jotkowitz A; Boos J; Dowling P; Rohowsky-Kochan C; Volmer T
    J Neurol Sci; 1997 Nov; 152(2):172-81. PubMed ID: 9415539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoadsorption (IA) versus plasma exchange (PE) in multiple sclerosis--first results of a double blind controlled trial.
    Schmitt E; Behm E; Buddenhagen F; Ernst B; Hitzschke B; Kracht M; Korten G; Kundt G; Meyer-Rienecker H; Osten B
    Prog Clin Biol Res; 1990; 337():289-92. PubMed ID: 2191322
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunological treatment of multiple sclerosis. II.
    Hughes RA
    J Neurol; 1986 Apr; 233(2):66-8. PubMed ID: 3009722
    [No Abstract]   [Full Text] [Related]  

  • 14. A prospective randomized trial of plasma exchange as additive therapy in idiopathic crescentic glomerulonephritis. The Canadian Apheresis Study Group.
    Cole E; Cattran D; Magil A; Greenwood C; Churchill D; Sutton D; Clark W; Morrin P; Posen G; Bernstein K
    Am J Kidney Dis; 1992 Sep; 20(3):261-9. PubMed ID: 1519607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Mayo Clinic experience with plasma exchange in chronic inflammatory-demyelinating polyneuropathy (CIDP).
    Dyck PJ; Pineda A; Swanson C; Low P; Windebank A; Daube J
    Prog Clin Biol Res; 1982; 106():197-204. PubMed ID: 6757940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of blinding on the results of a randomized, placebo-controlled multiple sclerosis clinical trial. 1994 [classical article].
    Noseworthy JH; Ebers GC; Vandervoort MK; Farquhar RE; Yetisir E; Roberts R
    Neurology; 2001 Dec; 57(12 Suppl 5):S31-5. PubMed ID: 11902593
    [No Abstract]   [Full Text] [Related]  

  • 18. Chronic progressive multiple sclerosis: double-blind controlled study of plasmapheresis in patients taking immunosuppressive drugs.
    Khatri BO; McQuillen MP; Harrington GJ; Schmoll D; Hoffmann RG
    Neurology; 1985 Mar; 35(3):312-9. PubMed ID: 3974889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An assessment of plasma exchange in progressive multiple sclerosis.
    Weiner HL
    Neurology; 1985 Mar; 35(3):320-2. PubMed ID: 3883234
    [No Abstract]   [Full Text] [Related]  

  • 20. Double blind controlled randomized study on azathioprine efficacy in multiple sclerosis. Preliminary results.
    Milanese C; La Mantia L; Salmaggi A; Campi A; Bortolami C; Tajoli L; Nespolo A; Corridori F
    Ital J Neurol Sci; 1988 Feb; 9(1):53-7. PubMed ID: 3281916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.